Plain-English translation of NCT06914557 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Nerve pain from chemotherapy can be severe and long-lasting, making it hard to do everyday activities. This trial tests whether adding Scrambler Therapy—a device that sends gentle electrical signals to help retrain how your nerves perceive pain—along with your current medication works better than medication alone.
While the medication duloxetine is the best treatment available for chemotherapy-related nerve pain, it only helps a little bit for many patients. Researchers want to see if combining this medication with a newer device-based treatment can give people more relief.
You likely qualify if…
You likely don't qualify if…
You will be assigned to one of two groups: one group will continue their current medication, while the other group will add Scrambler Therapy sessions to their medication routine. The therapy involves wearing electrodes on your skin while a machine sends gentle electrical signals. You'll attend treatment sessions at the cancer center while continuing to take your medication as prescribed.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States